BioNexus Gene Lab (BGLC) News Today $5.10 -1.53 (-23.08%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$4.69 -0.41 (-8.06%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BGLC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period BioNexus Gene Lab Corp. (BGLC) - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comBioNexus Gene Lab Corp. (BGLC) Stock Price Today - WSJJuly 2, 2025 | wsj.comBioNexus Gene Lab Corp News (BGLC) - Investing.comJuly 2, 2025 | investing.comBioNexus Gene Lab Names Chong Set Fui as CFOJune 23, 2025 | marketwatch.comBioNexus Gene Lab regains Nasdaq complianceMay 2, 2025 | uk.investing.comBioNexus Gene Lab Corp. Regains Compliance with Nasdaq Listing Rule and Enhances Growth StrategyMay 2, 2025 | nasdaq.comBioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth ...April 30, 2025 | gurufocus.comBioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth ReadinessApril 30, 2025 | globenewswire.comBioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth TrajectoryApril 15, 2025 | markets.businessinsider.comBioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth TrajectoryApril 15, 2025 | globenewswire.comBioNexus Gene Lab enacts reverse stock splitApril 11, 2025 | investing.comBioNexus Gene Lab Corp trading halted, news pendingApril 5, 2025 | markets.businessinsider.comBionexus Gene Lab enters partnership with ML TechMarch 7, 2025 | markets.businessinsider.comBioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury StrategyMarch 7, 2025 | globenewswire.comBioNexus Becomes First Nasdaq-Listed Firm To Adopt Ethereum TreasuryMarch 6, 2025 | msn.comBionexus Gene Lab announces board approval of Ethereum treasury strategyMarch 5, 2025 | markets.businessinsider.comBioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic WhitepaperMarch 5, 2025 | globenewswire.comBioNexus Gene Lab Leads Our Top 3 US Penny StocksDecember 6, 2024 | finance.yahoo.comBioNexus Gene Lab Faces Delisting and Leadership ChangesNovember 9, 2024 | markets.businessinsider.comBioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.September 25, 2024 | globenewswire.comBioNexus partners with Vitarray for gene detectionSeptember 15, 2024 | investing.comEuropean Central Bank cuts key interest rates as inflation fallsSeptember 15, 2024 | ca.finance.yahoo.comBioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.September 13, 2024 | globenewswire.comBioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare SolutionsSeptember 12, 2024 | globenewswire.comBioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste ProductionSeptember 11, 2024 | globenewswire.comBioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn BhdAugust 27, 2024 | globenewswire.comBioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn BhdAugust 26, 2024 | globenewswire.comBioNexus Gene Lab Second Quarter 2024 Earnings: US$0.005 loss per share (vs US$0.018 loss in 2Q 2023)August 18, 2024 | sg.finance.yahoo.comCyclezyme AB (CYCLE.ST)August 4, 2024 | finance.yahoo.comWhy Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day SessionApril 19, 2024 | msn.comWhy Is BioNexus Gene Lab (BGLC) Stock Down 27% Today?April 19, 2024 | investorplace.comBioNexus Gene Lab Invests in AI Healthcare CompanyApril 18, 2024 | marketwatch.comBioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareApril 18, 2024 | globenewswire.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Short Interest ReportFebruary 22, 2024 | benzinga.comBioNexus Gene Lab Stock (NASDAQ:BGLC), Analyst Ratings, Price Targets, PredictionsFebruary 22, 2024 | benzinga.comCompanies Like BioNexus Gene Lab (NASDAQ:BGLC) Can Afford To Invest In GrowthFebruary 14, 2024 | finance.yahoo.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 02:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 02:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 01:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 01:02 PM with a stated reason of "LULD pause." Trading set to resume at 01:02 PM. February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 01:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 01:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 01:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 01:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 01:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 12:02 PM with a stated reason of "LULD pause."...February 13, 2024 | marketbeat.comBioNexus Gene Lab (Nasdaq:BGLC) HeadlineTrading was temporarily halted for "BGLC" at 12:02 PM with a stated reason of "LULD pause." Trading set to resume at 12:02 PM. February 13, 2024 | marketbeat.com Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address BGLC Media Mentions By Week BGLC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BGLC News Sentiment▼0.000.57▲Average Medical News Sentiment BGLC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BGLC Articles This Week▼00▲BGLC Articles Average Week Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PIII News BDSX News BNR News BMGL News CCM News MRAI News ENZ News BRTX News MGRX News SSY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BGLC) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
